Histussin D (hydrocodone / pseudoephedrine) Drug Interactions
A total of 957 drugs (5419 brand and generic names) are known to interact with Histussin D (hydrocodone / pseudoephedrine).
- 386 major drug interactions (2234 brand and generic names)
- 559 moderate drug interactions (3117 brand and generic names)
- 12 minor drug interactions (68 brand and generic names)
Check for interactions with Histussin D (hydrocodone / pseudoephedrine)
Common medications checked in combination with Histussin D (hydrocodone / pseudoephedrine)
- Ambien (zolpidem)
- Ambien CR (zolpidem)
- Aquatab DM (dextromethorphan / guaifenesin)
- Aspirin Low Strength (aspirin)
- aspirin / methocarbamol
- benzonatate
- Biaxin (clarithromycin)
- Ceron-DM (chlorpheniramine / dextromethorphan / phenylephrine)
- enalapril / felodipine
- Guaifenesin DAC Liquid (codeine / guaifenesin / pseudoephedrine)
- hydrochlorothiazide
- Maxifed-G (guaifenesin / pseudoephedrine)
- naproxen
- PCE Dispertab (erythromycin)
- prednisone
- promethazine
- simvastatin
- tramadol
- Tussionex Pennkinetic (chlorpheniramine / hydrocodone)
- Ultram (tramadol)
Histussin D (hydrocodone / pseudoephedrine) alcohol/food Interactions
There is 1 alcohol/food interaction with Histussin D (hydrocodone / pseudoephedrine)
Histussin D (hydrocodone / pseudoephedrine) disease Interactions
There are 22 disease interactions with Histussin D (hydrocodone / pseudoephedrine) which include:
- Impaired Gi Motility
- Infectious Diarrhea
- Liver Disease
- Prematurity
- Renal Dysfunction
- Acute Alcohol Intoxication
- Drug Dependence
- Hypotension
- Intracranial Pressure
- Respiratory Depression
- Cardiovascular Disease
- Adrenal Insufficiency
- Biliary Spasm
- Hypothyroidism
- Seizure Disorders
- Urinary Retention
- Arrhythmias
- Gi Narrowing
- Pku
- Bph
- Diabetes
- Glaucoma
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
